Company · SOPH
SOPHiA GENETICS SA
Nasdaq's symbol directory lists SOPH on Nasdaq as “SOPHiA GENETICS SA - Ordinary Shares”.
In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($278K); insiders sold on 69 occasions ($4.2M); 12 planned-sale notices; 1 filing by holders of 5% or more.
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Jurgi Camblong, Executive Chairman sold $2.2M
- Xu Zhenyu, Chief Scientific Officer sold $730K
- Menu Philippe, Chief Medical Officer sold $402K
- Ross Muken, Chief Executive Officer sold $137K · bought $137K
- Verma Abhimanyu, Chief Technology Officer sold $266K
- George Cardoza, Chief Financial Officer sold $32K · bought $141K
- HIBBS KATHY L sold $154K
- Valente Manuela, Chief People Officer sold $135K
- Van Well Daan, Chief Legal Officer sold $117K
- Puylaert Kevin, Chief Sales Officer sold $3K
Every trade (71)
- SELLVan Well Daan, Chief Legal Officer sold $9K
- SELLXu Zhenyu, Chief Scientific Officer sold $32K
- SELLMenu Philippe, Chief Medical Officer sold $38K
- SELLJurgi Camblong, Executive Chairman sold $66K
- SELLHIBBS KATHY L sold $48K
- SELLVan Well Daan, Chief Legal Officer sold $10K
- BUYGeorge Cardoza, Chief Financial Officer bought $141K
- BUYRoss Muken, Chief Executive Officer bought $137K
- SELLXu Zhenyu, Chief Scientific Officer sold $29K
- SELLJurgi Camblong, Executive Chairman sold $62K
- SELLMenu Philippe, Chief Medical Officer sold $36K
- SELLJurgi Camblong, Executive Chairman sold $327K
- SELLRoss Muken, Chief Executive Officer sold $80K
- SELLMenu Philippe, Chief Medical Officer sold $60K
- SELLXu Zhenyu, Chief Scientific Officer sold $60K
- SELLVan Well Daan, Chief Legal Officer sold $50K
- SELLVerma Abhimanyu, Chief Technology Officer sold $43K
- SELLValente Manuela, Chief People Officer sold $34K
- SELLGeorge Cardoza, Chief Financial Officer sold $13K
- SELLPuylaert Kevin, Chief Sales Officer sold $2K
- SELLGeorge Cardoza, Chief Financial Officer sold $6K
- SELLRoss Muken, Chief Executive Officer sold $4K
- SELLMenu Philippe, Chief Medical Officer sold $39K
- SELLXu Zhenyu, Chief Scientific Officer sold $32K
- SELLVan Well Daan, Chief Legal Officer sold $47K
- SELLJurgi Camblong, Executive Chairman sold $65K
- SELLHIBBS KATHY L sold $51K
- SELLXu Zhenyu, Chief Scientific Officer sold $89K
- SELLHIBBS KATHY L sold $54K
- SELLMenu Philippe, Chief Medical Officer sold $43K
- SELLVerma Abhimanyu, Chief Technology Officer sold $44K
- SELLXu Zhenyu, Chief Scientific Officer sold $45K
- SELLXu Zhenyu, Chief Scientific Officer sold $39K
- SELLValente Manuela, Chief People Officer sold $79K
- SELLXu Zhenyu, Chief Scientific Officer sold $79K
- SELLVerma Abhimanyu, Chief Technology Officer sold $41K
- SELLXu Zhenyu, Chief Scientific Officer sold $30K
- SELLMenu Philippe, Chief Medical Officer sold $38K
- SELLJurgi Camblong, Executive Chairman sold $65K
- SELLJurgi Camblong, Executive Chairman sold $145K
- SELLXu Zhenyu, Chief Scientific Officer sold $124K
- SELLVerma Abhimanyu, Chief Technology Officer sold $38K
- SELLXu Zhenyu, Chief Scientific Officer sold $21K
- SELLJurgi Camblong, Executive Chairman sold $138K
- SELLXu Zhenyu, Chief Scientific Officer sold $69K
- SELLVerma Abhimanyu, Chief Technology Officer sold $35K
- SELLMenu Philippe, Chief Medical Officer sold $28K
- SELLJurgi Camblong, Executive Chairman sold $133K
- SELLJurgi Camblong, Executive Chairman sold $153K
- SELLMenu Philippe, Chief Medical Officer sold $29K
- SELLXu Zhenyu, Chief Scientific Officer sold $23K
- SELLJurgi Camblong, Executive Chairman sold $48K
- SELLJurgi Camblong, Executive Chairman sold $93K
- SELLJurgi Camblong, Executive Chairman sold $118K
- SELLRoss Muken, Chief Executive Officer sold $51K
- SELLXu Zhenyu, Chief Scientific Officer sold $38K
- SELLMenu Philippe, Chief Medical Officer sold $38K
- SELLVerma Abhimanyu, Chief Technology Officer sold $27K
- SELLValente Manuela, Chief People Officer sold $21K
- SELLGeorge Cardoza, Chief Financial Officer sold $8K
Showing the latest 60 of 71.
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- DAAN GUIDO MARIA VAN WELL $10K
- DAAN GUIDO MARIA VAN WELL $10K
- JURGI CAMBLONG $530K
- PHILIPPE MENU $181K
- ZHENYU XU $157K
- ROSS J MUKEN $79K
- DAAN GUIDO MARIA VAN WELL $50K
- MANUELA VALENTE $34K
- GEORGE CARDOZA $13K
- GEORGE CARDOZA $6K
- ROSS J MUKEN $3K
- DAAN GUIDO MARIA VAN WELL $47K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Schindel Yair Chaim 6.2%
Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.